Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus

被引：0
|
作者：
Liyao Fu
Ying Zhou
Jiaxing Sun
Zhaowei Zhu
Zhenhua Xing
Shenghua Zhou
Yongjun Wang
Shi Tai
机构：
[1] The Second Xiangya Hospital of Central South University,Department of Blood Transfusion
[2] The Second Xiangya Hospital of Central South University,Department of Cardiovascular Medicine
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Atherogenic index of plasma; Type 2 diabetes mellitus; Cardiovascular disease; Major adverse cardiovascular events; Atherosclerosis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients
    Liu, Mao-Jun
    Pei, Jun-Yu
    Zeng, Cheng
    Xing, Ying
    Zhang, Yi-Feng
    Tang, Pei-Qi
    Deng, Si-Min
    Hu, Xin-Qun
    WORLD JOURNAL OF DIABETES, 2025, 16 (03)
  • [42] Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes
    Ragot, Stephanie
    Saulnier, Pierre-Jean
    Velho, Gilberto
    Gand, Elise
    de Hauteclocque, Astrid
    Slaoui, Yousri
    Potier, Louis
    Sosner, Philippe
    Halimi, Jean-Michel
    Zaoui, Philippe
    Rigalleau, Vincent
    Fumeron, Frederic
    Roussel, Ronan
    Marre, Michel
    Hadjadj, Samy
    DIABETES CARE, 2016, 39 (07) : 1259 - 1266
  • [43] Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults
    Fei Hang
    Jieruo Chen
    Zefeng Wang
    Keyang Zheng
    Yongquan Wu
    Lipids in Health and Disease, 21
  • [44] Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults
    Hang, Fei
    Chen, Jieruo
    Wang, Zefeng
    Zheng, Keyang
    Wu, Yongquan
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [45] Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
    Resham L. Gurung
    Sylvia Liu
    Jian-Jun Liu
    Yiamunaa M.
    Huili Zheng
    Clara Chan
    Keven Ang
    Tavintharan Subramaniam
    Chee Fang Sum
    Su Chi Lim
    Cardiovascular Diabetology, 23
  • [46] Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
    Gurung, Resham L.
    Liu, Sylvia
    Liu, Jian-Jun
    M., Yiamunaa
    Zheng, Huili
    Chan, Clara
    Ang, Keven
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [47] Effect of dapagliflozin on the triglyceride-glucose index and the atherogenic index of plasma used as markers of atherosclerosis in patients with type 2 diabetes mellitus
    Gezer, Deniz
    Ozturk, Semra Ozkan
    Kocaman, Zehra
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (02) : 335 - 340
  • [48] Effect of dapagliflozin on the triglyceride-glucose index and the atherogenic index of plasma used as markers of atherosclerosis in patients with type 2 diabetes mellitus
    Deniz Gezer
    Semra Özkan Öztürk
    Zehra Kocaman
    International Journal of Diabetes in Developing Countries, 2024, 44 : 335 - 340
  • [49] Plasma B-type Natriuretic Peptide Levels Are Associated With Future Cardiovascular Events in Patients With Type 2 Diabetes Mellitus Without Known Cardiovascular Disease
    Ikeda, Shota
    Shinohara, Keisuke
    Enzan, Nobuyuki
    Matsushima, Shouji
    Tohyama, Takeshi
    Funakoshi, Kouta
    Kishimoto, Junji
    Itoh, Hiroshi
    Komuro, Issei
    Tsutsui, Hiroyuki
    CIRCULATION, 2020, 142
  • [50] Association of Remnant Lipoprotein Cholesterol, Type 2 Diabetes Mellitus, and Major Adverse Cardiovascular Events: Insights From the UK Biobank
    Gabani, Mohanad
    Kingsley, Jeffrey
    Rikhi, Rishi
    Chevli, Parag A.
    Herrington, David M.
    Shapiro, Michael D.
    CIRCULATION, 2023, 148
12345